Cited by 1,115Pluripotent Stem Cells ResearchDevelopmental Biology and Gene RegulationCancer-related Molecular Pathways

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Open access

Kawamura, Teruhisa, Suzuki, Jotaro, Wang, Yunyuan V., Menendez, Sergio, Morera, Laura Batlle, Raya, Angel, Wahl, Geoffrey M., Belmonte, Juan Carlos Izpisúa·2009·Nature

DOI 10.1038/nature08311PMC PMC2735889

Open this paper in CoChat — free account

Abstract

Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes, but the low frequency and tendency to induce malignant transformation compromise the clinical utility of this powerful approach. We address both issues by investigating the mechanisms limiting reprogramming efficiency in somatic cells. Here we show that reprogramming factors can activate the p53 (also known as Trp53 in mice, TP53 in humans) pathway. Reducing signalling to p53 by expressing a mutated version of one of its negative regulators, by deleting or knocking down p53 or its target gene, p21 (also known as Cdkn1a), or by antagonizing reprogramming-induced apoptosis in mouse fibroblasts increases reprogramming efficiency. Notably, decreasing p53 protein levels enabled fibroblasts to give rise to iPS cells capable of generating germline-transmitting chimaeric mice using only Oct4 (also known as Pou5f1) and Sox2. Furthermore, silencing of p53 significantly increased the reprogramming efficiency of human somatic cells. These results provide insights into reprogramming mechanisms and suggest new routes to more efficient reprogramming while minimizing the use of oncogenes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature08311

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626

Show all 40 references

Sorted by citations

Items 401–500 of 1,000

Oct4 Interaction with Hmgb2 Regulates Akt Signaling and Pluripotency
Campbell, P. A., & Rudnicki, M. A. (2013) · Stem Cells · doi:10.1002/stem.1365 · Cited by 46
Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis
Papa, L., Djedaini, M., & Hoffman, R. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14133 · Cited by 47
Survival signaling in the preimplantation embryo
O’Neill, C., Li, Y., & Jin, X. (2012) · Theriogenology · doi:10.1016/j.theriogenology.2011.12.016 · Cited by 45
Generation of Porcine-Induced Pluripotent Stem Cells by Using OCT4 and KLF4 Porcine Factors
Liu, K., Ji, G., Mao, J., Liu, M., Wang, L., Chen, C., & Liu, L. (2012) · Cellular Reprogramming · doi:10.1089/cell.2012.0047 · Cited by 44
Promotion of the induction of cell pluripotency through metabolic remodeling by thyroid hormone triiodothyronine-activated PI3K/AKT signal pathway
Chen, M., Zhang, H., Wu, J., Xu, L., Xu, D., Sun, J., He, Y., Zhou, X., Wang, Z., Wu, L., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.001 · Cited by 44
mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient
Heng, B. C., Heinimann, K., Miny, P., Iezzi, G., Glatz, K., Scherberich, A., Zulewski, H., & Fussenegger, M. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2013.02.004 · Cited by 45
Transcriptional Control of Somatic Cell Reprogramming
Xu, Y., Zhang, M., Li, W., Zhu, X., Bao, X., Qin, B., Hutchins, A. P., & Esteban, M. A. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.003 · Cited by 46
Lysine methylation represses p53 activity in teratocarcinoma cancer cells
Zhu, J., Dou, Z., Sammons, M. A., Levine, A. J., & Berger, S. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610387113 · Cited by 44
Mdm2 as a chromatin modifier
Wienken, M., Moll, U. M., & Dobbelstein, M. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw046 · Cited by 44
MicroRNAs: Important Regulators of Induced Pluripotent Stem Cell Generation and Differentiation
Zeng, Z., Lin, X., Tan, L.-L., Liu, Y., Qu, K., & Wang, Z. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9785-6 · Cited by 46
Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism
Liu, J., Brzeszczyńska, J., Samuel, K., Black, J., Palakkan, A. A., Anderson, R. A., Gallagher, R., & Ross, J. A. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.08.004 · Cited by 43
Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine
Anastasia, L., Pelissero, G., Venerando, B., & Tettamanti, G. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.14 · Cited by 44
Global DNA Hypomethylation Prevents Consolidation of Differentiation Programs and Allows Reversion to the Embryonic Stem Cell State
Schmidt, C. S., Bultmann, S., Meilinger, D., Zacher, B., Tresch, A., Maier, K. C., Peter, C., Martin, D. E., Leonhardt, H., & Spada, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052629 · Cited by 44
A Novel Small Molecule Facilitates the Reprogramming of Human Somatic Cells into a Pluripotent State and Supports the Maintenance of an Undifferentiated State of Human Pluripotent Stem Cells
Lee, J., Xia, Y., Son, M., Jin, G., Seol, B., Kim, M., Son, M. J., Do, M., Lee, M., Kim, D., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201206691 · Cited by 42
p53 switches off pluripotency on differentiation
Lin, T., & Lin, Y. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0498-1 · Cited by 44
Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation
Papa, L., Zimran, E., Djedaini, M., Ge, Y., Özbek, U., Sebra, R., Sealfon, S. C., & Hoffman, R. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024273 · Cited by 43
Patient-Specific Pluripotent Stem Cells in Neurological Diseases
Durnaoglu, S., Genç, Ş., & Genç, K. (2011) · Stem Cells International · doi:10.4061/2011/212487 · Cited by 44
Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability
Fukawatase, Y., Toyoda, M., Okamura, K., Nakamura, K.-I., Nakabayashi, K., Takada, S., Yamazaki‐Inoue, M., Masuda, A., Nasu, M., Hata, K., et al. (2014) · Scientific Reports · doi:10.1038/srep05421 · Cited by 41
Tp53 Suppression Promotes Cardiomyocyte Proliferation during Zebrafish Heart Regeneration
Shoffner, A. R., Cigliola, V., Lee, N., Ou, J., & Poss, K. D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108089 · Cited by 46
Telomeres And Telomerase in Adult Stem Cells and Pluripotent Embryonic Stem Cells
Marión, R. M., & Blasco, M. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4_9 · Cited by 46
Physiological cellular reprogramming and cancer
Abollo‐Jiménez, F., Jiménez, R., & Cobaleda, C. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.02.002 · Cited by 42
A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice
Leonova, K. I., Shneyder, J., Antoch, M. P., Toshkov, I. A., Novototskaya, L. R., Komarov, P. G., Komarova, E. A., & Gudkov, A. V. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11508 · Cited by 40
Therapeutic targeting of the p53 pathway in cancer stem cells
Prabhu, V. V., Allen, J. E., Hong, B., Zhang, S., Cheng, H., & El‐Deiry, W. S. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.726985 · Cited by 40
Genomic instability during reprogramming by nuclear transfer is DNA replication dependent
Chia, G., Agudo, J., Treff, N. R., Sauer, M. V., Billing, D. L., Brown, B. D., Baer, R. J., & Egli, D. M. (2017) · Nature Cell Biology · doi:10.1038/ncb3485 · Cited by 40
Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency
Araki, R., Hoki, Y., Suga, T., Obara, C., Sunayama, M., Imadome, K., Fujita, M., Kamimura, S., Nakamura, M., Wakayama, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13830-x · Cited by 42
Loss of a single allele for Ku80 leads to progenitor dysfunction and accelerated aging in skeletal muscle
Didier, N., Hourdé, C., Amthor, H., Marazzi, G., & Sassoon, D. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101075 · Cited by 43
Looking to the future following 10 years of induced pluripotent stem cell technologies
Li, M., & Belmonte, J. C. I. (2016) · Nature Protocols · doi:10.1038/nprot.2016.108 · Cited by 44
Self-citation
Downregulation of p53 drives autophagy during human trophoblast differentiation
Gauster, M., Maninger, S., Siwetz, M., Deutsch, A. J. A., Heliebi, A. E., Kolb-Lenz, D., Hiden, U., Desoyé, G., Herse, F., & Prokesch, A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2695-6 · Cited by 40
Label-free analysis of the characteristics of a single cell trapped by acoustic tweezers
Kim, M., Park, J., Lim, H. G., Yoon, S., Lee, C., Chang, J. H., & Shung, K. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-14572-w · Cited by 40
Reawakening the Developmental Origins of Cancer Through Transposable Elements
Lynch‐Sutherland, C. F., Chatterjee, A., Stockwell, P. A., Eccles, M. R., & Macaulay, E. C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00468 · Cited by 43
Induced Pluripotent Stem Cells: Emerging Techniques for Nuclear Reprogramming
Han, J. W., & Yoon, Y. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3814 · Cited by 43
Pluripotent Reprogramming of Fibroblasts by Lentiviralmediated Insertion of SOX2, C-MYC, and TCL-1A
Picanço‐Castro, V., Russo, E. M. D. S., Reis, L. C. J., Fraga, A. M., Magalhães, D. A., Orellana, M. D., Panepucci, R. A., Pereira, L. V., & Covas, D. T. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0424 · Cited by 44
Cell cycle regulation in human embryonic stem cells: links to adaptation to cell culture
Bárta, T., Bohačiaková, D., Holubcová, Z., & Hampl, A. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213480711 · Cited by 39
Inhibition of PTEN Tumor Suppressor Promotes the Generation of Induced Pluripotent Stem Cells
Liao, J., Marumoto, T., Yamaguchi, S., Okano, S., Takeda, N., Sakamoto, C., Kawano, H., Nii, T., Miyamoto, S., Nagai, Y., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.60 · Cited by 40
Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression
Sachweh, M. C. C., Drummond, C. J., Higgins, M., Campbell, J., & Laı́n, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.61 · Cited by 38
Blockade of senescence‐associated micro RNA ‐195 in aged skeletal muscle cells facilitates reprogramming to produce induced pluripotent stem cells.
Kondo, H., Kim, H. W., Wang, L., Okada, M., Paul, C., Millard, R. W., & Wang, Y. (2015) · Aging Cell · doi:10.1111/acel.12411 · Cited by 39
Self-citation
LncRNAs regulating stemness in aging
Sousa‐Franco, A., Rebelo, K., da Rocha, S. T., & de Jesus, B. B. (2018) · Aging Cell · doi:10.1111/acel.12870 · Cited by 38
Dichloroacetate, the Pyruvate Dehydrogenase Complex and the Modulation of mESC Pluripotency
Rodrigues, A. S., Correia, M., Gomes, A. M., Pereira, S. L., Perestrelo, T., Sousa, M. I., & Ramalho‐Santos, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131663 · Cited by 39
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes
Cordani, N., Pozzi, S., Martynova, E., Fanoni, D., Borrelli, S., Alotto, D., Castagnoli, C., Berti, E., Viganò, M., & Mantovani, R. (2010) · Oncogene · doi:10.1038/onc.2010.474 · Cited by 42
Analogy between sphere forming ability and stemness of human hepatoma cells
Tanaka (2010) · Oncology Reports · doi:10.3892/or_00000966 · Cited by 39
The emerging functions of the p53-miRNA network in stem cell biology
Lin, C.-P., Choi, Y. J., Hicks, G. G., & He, L. (2012) · Cell Cycle · doi:10.4161/cc.20207 · Cited by 38
Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells
Yi, L., Sun, Y., & Levine, A. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2441 · Cited by 39
Impact of new technologies for cellular screening along the drug value chain
Möller, C., & Slack, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.010 · Cited by 38
Identification and characterization of an oocyte factor required for development of porcine nuclear transfer embryos
Miyamoto, K., Nagai, K., Kitamura, N., Nishikawa, T., Ikegami, H., Binh, N. T., Tsukamoto, S., Matsumoto, M., Tsukiyama, T., Minami, N., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013634108 · Cited by 38
Werner Syndrome-specific induced pluripotent stem cells: recovery of telomere function by reprogramming
Shimamoto, A., Yokote, K., & Tahara, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00010 · Cited by 38
Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy
Louwen, F., & Yuan, J. (2013) · Oncotarget · doi:10.18632/oncotarget.1096 · Cited by 38
Impact papers on aging in 2009
Blagosklonny, M. V., Campisi, J., Sinclair, D. A., Bartke, A., Blasco, M. A., Bonner, W. M., Bohr, V. A., Brosh, R. M., Brunet, A., DePinho, R. A., et al. (2010) · Aging · doi:10.18632/aging.100132 · Cited by 38
Foxm1 controls a pro-stemness microRNA network in neural stem cells
Besharat, Z. M., Abballe, L., Cicconardi, F., Bhutkar, A. J., Grassi, L., Pera, L. L., Moretti, M., Chinappi, M., D’Andrea, D., Mastronuzzi, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21876-y · Cited by 39
Few Single Nucleotide Variations in Exomes of Human Cord Blood Induced Pluripotent Stem Cells
Su, R.-J., Yang, Y., Neises, A., Payne, K. J., Wang, J., Viswanathan, K., Wakeland, E. K., Fang, X., & Zhang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059908 · Cited by 37
Regulation of Stem Cell Plasticity: Mechanisms and Relevance to Tissue Biology and Cancer
Strauss, R., Hamerlik, P., Lieber, A., & Bartek, J. (2012) · Molecular Therapy · doi:10.1038/mt.2012.2 · Cited by 41
Mutations in Bone Marrow-Derived Stromal Stem Cells Unmask Latent Malignancy
Houghton, J., Li, H., Fan, X., Liu, Y., Liu, J. H., Rao, V. P., Poutahidis, T., Taylor, C. L., Jackson, E. A., Hewes, C., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0439 · Cited by 36
Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells
Felgentreff, K., Du, L., Weinacht, K. G., Dobbs, K., Bartish, M., Giliani, S., Schlaeger, T. M., DeVine, A. L., Schambach, A., Woodbine, L. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323649111 · Cited by 37
Crosstalk between stem cell and cell cycle machineries
Kareta, M. S., Sage, J., & Wernig, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.10.001 · Cited by 37
Potential application of cell reprogramming techniques for cancer research
Saito, S., Lin, Y., Nakamura, Y., Eckner, R., Wuputra, K., Kuo, K., Lin, C., & Yokoyama, K. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2924-7 · Cited by 38
Embryonic Stem Cells and Induced Pluripotent Stem Cells for Skeletal Regeneration
Park, S., & Im, G. (2013) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2013.0530 · Cited by 37
Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors
Hede, S., Nazarenko, I., Nistér, M., & Lindström, M. S. (2010) · Journal of Oncology · doi:10.1155/2011/852970 · Cited by 40
Understanding the roadmaps to induced pluripotency
Liu, K., Song, Y., Yu, H., & Zhao, T. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.205 · Cited by 36
Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs
Yang, C., & Rana, T. M. (2012) · Molecular BioSystems · doi:10.1039/c2mb25088h · Cited by 36
Novel Pathways Revealed in Bursa of Fabricius Transcriptome in Response to Extraintestinal Pathogenic Escherichia coli (ExPEC) Infection
Sun, H., Liu, P., Nolan, L. K., & Lamont, S. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142570 · Cited by 35
The Genomic Health of Human Pluripotent Stem Cells: Genomic Instability and the Consequences on Nuclear Organization
Henry, M. P., Hawkins, J. R., Boyle, J., & Bridger, J. M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00623 · Cited by 42
Remodeling of mitochondrial morphology and function: an emerging hallmark of cellular reprogramming
Rastogi, A., Joshi, P. K., Contreras, E., & Gama, V. (2019) · Cell Stress · doi:10.15698/cst2019.06.189 · Cited by 36
Deciphering the roadmap of in vivo reprogramming toward pluripotency
Chondronasiou, D., Martínez de Villarreal, J., Melendez, E., Lynch, C. J., Pozo, N. D., Kovatcheva, M., Aguilera, M., Prats, N., Real, F. X., & Serrano, M. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.09.009 · Cited by 34
Induced pluripotent stem cells: advances to applications
Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Ikeda, Y., Perez-Terzic, C., & Terzic, A. (2009) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s4954 · Cited by 36
How far are induced pluripotent stem cells from the clinic?
Li, M.-R., Chen, M.-X., Han, W.-D., & Fu, X.-B. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.03.001 · Cited by 38
A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation
Li, Y., & Geng, Y. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.09.005 · Cited by 35
Metabolome and metaboproteome remodeling in nuclear reprogramming
Folmes, C. D. L., Arrell, D. K., Zlatković, J., Martinez‐Fernandez, A., Pérez-Terzic, C. M., Nelson, T. J., & Terzic, A. (2013) · Cell Cycle · doi:10.4161/cc.25509 · Cited by 35
Comparison of Reprogramming Efficiency Between Transduction of Reprogramming Factors, Cell–Cell Fusion, and Cytoplast Fusion
Hasegawa, K., Zhang, P., Wei, Z., Pomeroy, J. E., Lu, W., & Pera, M. F. (2010) · Stem Cells · doi:10.1002/stem.466 · Cited by 35
p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming
Gong, L., Pan, X., Chen, H., Rao, L., Zeng, Y., Hang, H., Peng, J., Xiao, L., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep37281 · Cited by 37
Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors
Cheng, H., Ang, H. Y.-K., Farran, C. A. E., Li, P., Fang, H., Liu, T. M., Kong, S. L., Chin, M. L., Ling, W. Y., Lim, E. K. H., et al. (2016) · Nature Communications · doi:10.1038/ncomms13396 · Cited by 35
Mechanisms of Congenital Malformations in Pregnancies with Pre-existing Diabetes
Loeken, M. R. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01338-4 · Cited by 43
Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
Kotini, A. G., Carcamo, S., Cruz‐Rodriguez, N., Olszewska, M., Wang, T., Demircioğlu, D., Chang, C.-J., Bernard, E., Chao, M. P., Majeti, R., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0167 · Cited by 37
Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation
Jabbour, A. M., Daunt, C. P., Green, B. D., Vogel, S., Gordon, L., Lee, R. S., Silke, N., Pearson, R. B., Vandenberg, C. J., Kelly, P. N., et al. (2009) · Blood · doi:10.1182/blood-2009-07-230730 · Cited by 34
Enhancing the efficiency of direct reprogramming of human primary fibroblasts into dopaminergic neuron-like cells through p53 suppression
Liu, X.-J., Huang, Q., Li, F., & Li, C.-Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4730-2 · Cited by 29
Apoptosis: Reprogramming and the Fate of Mature Cells
Cheung, H., Liu, X., & Rennert, O. M. (2012) · ISRN Cell Biology · doi:10.5402/2012/685852 · Cited by 32
Stem Cells: The Pursuit of Genomic Stability
Wyles, S. P., Brandt, E. B., & Nelson, T. J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120948 · Cited by 36
p53 and p73 Regulate Apoptosis but Not Cell-Cycle Progression in Mouse Embryonic Stem Cells upon DNA Damage and Differentiation
He, H., Wang, C., Dai, Q., Li, F., Bergholz, J. S., Li, Z., Li, Q., & Xiao, Z. J. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.10.008 · Cited by 34
TRIM28 epigenetic corepressor is indispensable for stable induced pluripotent stem cell formation
Klimczak, M., Czerwińska, P., Mazurek, S., Sozańska, B., Biecek, P., Mackiewicz, A. A., & Wiznerowicz, M. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.07.012 · Cited by 34
miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1–Sox2 axis
Zhang, Y., Pan, Y., Xie, C., & Zhang, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0778-4 · Cited by 34
Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance
Pillai, V. V., Kei, T. G., Reddy, S. E., Das, M., Abratte, C. M., Cheong, S. H., & Selvaraj, V. (2019) · Animal Science Journal · doi:10.1111/asj.13272 · Cited by 33
Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues
Alle, Q., Le Borgne, E., Milhavet, O., & Lemaitre, J.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083990 · Cited by 35
Wild-type and Hupki (Human p53 Knock-in) Murine Embryonic Fibroblasts
Whibley, C. E., Odell, A. F., Nedelko, T., Balaburski, G. M., Murphy, M. E., Liu, Z., Stevens, L., Walker, J. H., Routledge, M. N., & Hollstein, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064444 · Cited by 33
Induction of Retinal Progenitors and Neurons from Mammalian Müller Glia under Defined Conditions
Zhao, J. J., Ouyang, H. W., Luo, J., Patel, S. H., Xue, Y., Quach, J., Sfeir, N., Zhang, M., Fu, X., Ding, S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532671 · Cited by 33
Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling
Li, W., Chen, S., & Li, J. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.009 · Cited by 35
Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo
Hao, E., Li, G., Liang, Y., Xie, M., Wang, D., Jiang, X., Cheng, J., Shi, Z., Wang, Y., & Guo, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01717 · Cited by 33
Self-citation
Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe
Asl, E. R., Rostamzadeh, D., Duijf, P. H. G., Mafi, S., Mansoori, B., Barati, S., Cho, W. C. S., & Mansoori, B. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121361 · Cited by 38
The relevance of protein-protein interactions for p53 function: the CPE contribution
Fernández-Fernández, M. R., & Sot, B. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq074 · Cited by 33
10th anniversary of iPS cells: the challenges that lie ahead
Aoi, T. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw044 · Cited by 33
Valproic Acid Enhances iPSC Induction From Human Bone Marrow-Derived Cells Through the Suppression of Reprogramming-Induced Senescence
Chen, X. X., Zhai, Y., Yu, D., Cui, J., Hu, J., & Li, W. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25270 · Cited by 33
The role of NF-κB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection
Bano, N., Yadav, M. C., Mohania, D., & Das, B. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205518 · Cited by 32
Retracted
p53 balances between tissue hierarchy and anarchy
Koifman, G., Aloni-Grinstein, R., & Rotter, V. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz022 · Cited by 33
MicroRNAs in Cancer Translational Research
Cho, W. C. S. (2011) · Springer eBooks · doi:10.1007/978-94-007-0298-1 · Cited by 32
PRMT 5 enhances generation of induced pluripotent stem cells from dairy goat embryonic fibroblasts via down‐regulation of p53
Chu, Z., Niu, B., Zhu, H., He, X., Bai, C., Li, G., & Hua, J. (2014) · Cell Proliferation · doi:10.1111/cpr.12150 · Cited by 31
Stem cell biology meets p53
Puzio‐Kuter, A. M., & Levine, A. J. (2009) · Nature Biotechnology · doi:10.1038/nbt1009-914 · Cited by 31
The ups and downs of p53 regulation in hematopoietic stem cells
Abbas, H. A., Pant, V., & Lozano, G. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17721 · Cited by 33
Drug-loaded nanoparticles induce gene expression in human pluripotent stem cell derivatives
Gajbhiye, V., Escalante, L. E., Chen, G., Laperle, A., Zheng, Q., Steyer, B., Gong, S., & Saha, K. (2013) · Nanoscale · doi:10.1039/c3nr04794f · Cited by 31
Modeling blood diseases with human induced pluripotent stem cells
Georgomanoli, M., & Papapetrou, E. P. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039321 · Cited by 35
Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylation
Jia, L., Wang, Y., Wang, C., Du, Z., Zhang, S., Wen, X., Zhou, L., Li, H. Z., Chen, H., Li, D., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa097 · Cited by 32
Self-citation
Chromosomal aberration arises during somatic reprogramming to pluripotent stem cells
Liu, X., Li, C., Zheng, K., Zhao, X., Xu, X., Yang, A., Yi, M., Tao, H., Xie, B., Qiu, M. S., et al. (2020) · Cell Division · doi:10.1186/s13008-020-00068-z · Cited by 33
Context‐Dependent Enhancement of Induced Pluripotent Stem Cell Reprogramming by Silencing Puma
Lake, B. B., Fink, J., Klemetsaune, L., Fu, X., Jeffers, J. R., Zambetti, G. P., & Xu, Y. (2012) · Stem Cells · doi:10.1002/stem.1054 · Cited by 30
Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells
Li, C., Finkelstein, D., & Sherr, C. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302184110 · Cited by 32

Authors: Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I.
Affiliations: Salk Institute for Biological Studies (US)
Corresponding author: Wahl, Geoffrey M.
Belmonte, Juan Carlos Izpisúa
ORCID: Kawamura, Teruhisa
Wahl, Geoffrey M.
Belmonte, Juan Carlos Izpisúa
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2009-08
Volume: 460
Issue: 7259
Pages: 1140-1144
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature08311
PMC: PMC2735889
OpenAlex: W2070672434
Cited by: 1,115
References: 40
Citations by year: 2026: 13 · 2025: 12 · 2024: 30 · 2023: 34 · 2022: 31 · 2021: 36 · 2020: 29 · 2019: 41 · 2018: 55 · 2017: 60 · 2016: 65 · 2015: 77 · 2014: 96 · 2013: 111 · 2012: 136
FWCI: 57.10
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (R33HL088293)
National Cancer Institute (R01CA100845, R01CA061449)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: p53, somatic cell reprogramming, induced pluripotent stem cells, Oct4, SOX2, p21, Nutlin-3, reprogramming efficiency, malignant transformation, fibroblasts, oncogenes, apoptosis
MeSH terms: Animals, Cells, Cultured, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Mice, Inbred C57BL, Down-Regulation, Keratinocytes, Tumor Suppressor Protein p53, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks